The Eagle Effect and Antibiotic-Induced Persistence: Two Sides of the Same Coin?

被引:45
作者
Prasetyoputri, Anggia [1 ,2 ]
Jarrad, Angie M. [3 ]
Cooper, Matthew A. [1 ]
Blaskovich, Mark A. T. [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, Ctr Superbug Solut, 306 Carmody Rd, Brisbane, Qld 4072, Australia
[2] Indonesian Inst Sci, Res Ctr Biotechnol, Cibinong 16911, Indonesia
[3] Helmholtz Ctr Infect Res, Dept Chem Biol, D-38124 Braunschweig, Germany
基金
英国惠康基金; 澳大利亚国家健康与医学研究理事会;
关键词
IN-VITRO SUSCEPTIBILITY; CELL-WALL CHITIN; CANDIDA-ALBICANS; STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ACTIVITY; PARADOXICAL GROWTH; ENTEROCOCCUS-FAECALIS; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; STREPTOCOCCUS-PNEUMONIAE;
D O I
10.1016/j.tim.2018.10.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Eagle effect describes a phenomenon in which bacteria or fungi exposed to concentrations of antibiotic higher than an optimal bactericidal concentration (OBC) have paradoxically improved levels of survival than at the OBC due to a decreased net rate of cell death. Despite extensive observational reports of this effect in different microorganisms, its underlying mode of action is not well understood. Although aspects of the Eagle effect resemble persistence, there is strong evidence that these phenomena are substantially different phenotypic responses to antibiotic treatment. We present an overview of the microorganism and antimicrobial combinations in which the Eagle effect has been observed. Proposed underlying mechanism(s) are assessed, and the Eagle effect and microbial persistence are compared and contrasted. The clinical relevance of the Eagle effect is reviewed, incorporating evidence from experimental in vitro and in vivo studies, as well as clinical reports.
引用
收藏
页码:339 / 354
页数:16
相关论文
共 134 条
  • [1] Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections
    Aguinagalde, Leire
    Diez-Martinez, Roberto
    Yuste, Jose
    Royo, Inmaculada
    Gil, Carmen
    Lasa, Inigo
    Martin-Fontecha, Mar
    Marin-Ramos, Nagore Isabel
    Ardanuy, Carmen
    Linares, Josefina
    Garcia, Pedro
    Garcia, Ernesto
    Sanchez-Puelles, Jose M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (09) : 2608 - 2617
  • [2] Metabolite-enabled eradication of bacterial persisters by aminoglycosides
    Allison, Kyle R.
    Brynildsen, Mark P.
    Collins, James J.
    [J]. NATURE, 2011, 473 (7346) : 216 - +
  • [3] Persister Heterogeneity Arising from a Single Metabolic Stress
    Amato, Stephanie M.
    Brynildsen, Mark P.
    [J]. CURRENT BIOLOGY, 2015, 25 (16) : 2090 - 2098
  • [4] Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia
    Antachopoulos, Charalampos
    Meletiadis, Joseph
    Sein, Tin
    Roilides, Emmanuel
    Walsh, Thomas J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) : 321 - 328
  • [5] Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans
    Arai, R
    Sugita, T
    Nishikawa, A
    [J]. MYCOSES, 2005, 48 (01) : 38 - 41
  • [6] Bacterial persistence as a phenotypic switch
    Balaban, NQ
    Merrin, J
    Chait, R
    Kowalik, L
    Leibler, S
    [J]. SCIENCE, 2004, 305 (5690) : 1622 - 1625
  • [7] Heterogeneous Persister Cells Formation in Acinetobacter baumannii
    Barth, Valdir Cristovao, Jr.
    Rodrigues, Belisa Avila
    Bonatto, Grasiela Daiane
    Gallo, Stephanie Wagner
    Pagnussatti, Vany Elisa
    Sanchez Ferreira, Carlos Alexandre
    de Oliveira, Silvia Dias
    [J]. PLOS ONE, 2013, 8 (12):
  • [8] The sequential activation of the yeast HOG and SLT2 pathways is required for cell survival to cell wall stress
    Bermejo, Clara
    Rodriguez, Estefania
    Garcia, Raul
    Rodriguez-Pena, Jose M.
    Rodriguez de la Concepcion, Maria L.
    Rivas, Carmen
    Arias, Patricia
    Nombela, Cesar
    Posas, Francesc
    Arroyo, Javier
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2008, 19 (03) : 1113 - 1124
  • [9] A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
    Betts, Robert F.
    Nucci, Marcio
    Talwar, Deepak
    Gareca, Marcelo
    Queiroz-Telles, Flavio
    Bedimo, Roger J.
    Herbrecht, Raoul
    Ruiz-Palacios, Guillermo
    Young, Jo-Anne H.
    Baddley, John W.
    Strohmaier, Kim M.
    Tucker, Kimberly A.
    Taylor, Arlene F.
    Kartsonis, Nicholas A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) : 1676 - 1684
  • [10] Bigger JW, 1944, LANCET, V2, P497